期刊文献+

固体纳米晶体给药系统构建方法的研究进展 被引量:16

The research progress of preparation methods of solid nanocrystal delivery system
原文传递
导出
摘要 纳米晶体混悬给药系统可有效解决难溶性药物递药的问题,然而液体纳米晶体给药系统的物理稳定性差。固体纳米晶体给药系统作为液态纳米晶体混悬给药系统的一种改良技术,可克服液体纳米晶体混悬系统热动力学不稳定的现象,同时方便患者携带和使用,临床顺应性好,是实现纳米晶体混悬给药系统稳定化的理想选择。本文主要综述了固体纳米晶体给药系统的纳米化与固体化构建方法的研究进展,期望为该递药系统的发展提供借鉴与思考。 Nanocrystal suspensions drug delivery system is used to solve the delivery difficulty of poorly soluble drug. However, the physical stability of liquid nanocrystal suspensions is very bad. Solid nanocrystal delivery system as a novel technology, can improve the thermokinetics stability of nanocrystal suspensions and have good clinical compliance, which can achieve stabilization of nanocrystal suspension systems as an ideal delivery system. In this paper, we reviewed the research progress of nanotechnology and solidification technology of solid nanocrystal suspension delivery system, which will give the new mirrors and thoughts on the development of solid nanocrystal delivery system.
出处 《药学学报》 CAS CSCD 北大核心 2012年第9期1120-1127,共8页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(81102821) 教育部留学归国人员创新基金资助项目(20101561) 北京市自然科学基金资助项目(7122176) 江西省卫生厅中医药科研项目(2011A134) 江西中医学院重点学科青年基金资助项目(2009zdxk015)
关键词 固体纳米晶体给药系统 纳米化 固体化 solid nanocrystal delivery system nanotechnology solidification technology
  • 相关文献

参考文献3

二级参考文献57

  • 1朱建芬,吴祥根.纳米混悬剂的制备方法及在药剂学中应用的研究进展[J].中国医药工业杂志,2006,37(3):196-200. 被引量:38
  • 2陈华,刘亚青.超临界流体快速膨胀法制备微细颗粒[J].化工科技,2006,14(6):44-48. 被引量:1
  • 3Kipp JE. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs [J]. Int J Pharm, 2004, 284 (1-2): 109-122.
  • 4Duchene D, Bochot A, Yu SC, et al. Cyclodextrins and emulsions[J].Int J Pharm, 2003, 266 (1-2) : 85-90.
  • 5Suitthimeathegorn O, Jaitely V, Florence AT. Novel anhydrous emulsions: formulation as controlled release vehicles [J]. Int J Pharm, 2005, 298 (2): 367-371.
  • 6Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the future[J]. Adv Drug Deliv Rev, 2001, 47 (1) : 3-19.
  • 7Fakes MG, Vakkalagadda B J, Qian F, et al. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches [J]. Int J Pharm, 2009, 370(1-2): 167-174.
  • 8Moschwitzer J, Achleitner G, Pomper H, et al. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology [J]. Eur J Pharm Biopharm, 2004, 58 (3) : 615-619.
  • 9Pilcer G, Vanderbist F, Amighi K. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery [J3. Int J Pharm, 2009, 365 (1-2) : 162-169.
  • 10Mishra PR, Al Shaal L, Muller RH, et al. Production and characterization of Hesperetin nanosuspensions for dermal delivery [J]. Int J Pharm, 2009, 371 (1-2): 182-189.

共引文献45

同被引文献196

引证文献16

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部